Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs Allbirds Inc — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Allbirds Inc trades at $3.39 (market cap $30.69M). The key difference: Adaptive Biotechnologies Corp is far larger — about 108.5× Allbirds Inc's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | BIRD | |
|---|---|---|
Market Cap | $3.33B | $30.69M |
Sector | Health | Consumer Cyclical |
52-Week High | $22.37 | $16.99 |
52-Week Low | $10.24 | $2.39 |
Enterprise Value | $3.19B | $49.56M |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →